Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 08/11/19951 min de lecture
Advisory Committee Meetings; Amendment of Notice
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. The meeting was announced in the Federal Register of October 20, 1995 (60 FR 54233). The amendment is being made to remove probucol, new drug application (NDA) 17-535 (Lorelco , Hoechst Marion Roussel) for a lipid altering indication from the agenda, and change the time schedule. There are no other changes. This amendment will be announced at the beginning of the open portion of the meeting.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →